Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew M Tonkin

Showing results (11-20 of 170) with videos related to

Pageof 17
Sort By:
Current Opinion in Lipidology|November 21, 2002
Further evidence of the need to establish treatment safety as well as efficacy in randomized controlled trialsAndrew M Tonkin, Carlos A Dujovne
The Medical Journal of Australia|March 8, 2021
Assessing and modifying cardiovascular risk in people who present to a chest pain clinic with non-cardiac causesJohannes T Neumann, Andrew M Tonkin
Lancet (London, England)|November 13, 2012
Into the future: diversifying lipid managementAndrew M Tonkin, Gerald F Watts
Circulation|September 23, 2009
The importance of extinguishing secondhand smokeAndrew M Tonkin, Alison Beauchamp, Christopher Stevenson
The Medical Journal of Australia|September 23, 2009
Maximising the effectiveness and cost-effectiveness of cardiovascular disease prevention in the general populationAndrew M Tonkin, Andrew N Boyden, Stephen Colagiuri
European Heart Journal|November 18, 2025
Long-term cardiovascular events and bleeding in the ASPREE studyRory Wolfe, Michael E Ernst, Andrew M Tonkin
The Medical Journal of Australia|February 1, 2003
Cardiovascular risk factors: when should we treat?Andrew M Tonkin, Stephen S Lim, Henrik Schirmer
The Medical Journal of Australia|November 12, 2003
Public funding of large-scale clinical trials in AustraliaJohn J McNeil, Mark R Nelson, Andrew M Tonkin
Progress in Cardiovascular Diseases|July 7, 2026
Caution: very high HDL-cholesterolSultana Monira Hussain, Andrew M Tonkin, John J McNeil
BJOG : an International Journal of Obstetrics and Gynaecology|January 10, 2006
Hormone therapy and cardiovascular disease: a systematic review and meta-analysisDianna J Magliano, Sophie L Rogers, Michael J Abramson, et al.
Pageof 17

Showing results (11-20 of 170) with videos related to

Sort By:
Pageof 17
Current Opinion in Lipidology|November 21, 2002
Further evidence of the need to establish treatment safety as well as efficacy in randomized controlled trialsAndrew M Tonkin, Carlos A Dujovne
The Medical Journal of Australia|March 8, 2021
Assessing and modifying cardiovascular risk in people who present to a chest pain clinic with non-cardiac causesJohannes T Neumann, Andrew M Tonkin
Lancet (London, England)|November 13, 2012
Into the future: diversifying lipid managementAndrew M Tonkin, Gerald F Watts
Circulation|September 23, 2009
The importance of extinguishing secondhand smokeAndrew M Tonkin, Alison Beauchamp, Christopher Stevenson
The Medical Journal of Australia|September 23, 2009
Maximising the effectiveness and cost-effectiveness of cardiovascular disease prevention in the general populationAndrew M Tonkin, Andrew N Boyden, Stephen Colagiuri
European Heart Journal|November 18, 2025
Long-term cardiovascular events and bleeding in the ASPREE studyRory Wolfe, Michael E Ernst, Andrew M Tonkin
The Medical Journal of Australia|February 1, 2003
Cardiovascular risk factors: when should we treat?Andrew M Tonkin, Stephen S Lim, Henrik Schirmer
The Medical Journal of Australia|November 12, 2003
Public funding of large-scale clinical trials in AustraliaJohn J McNeil, Mark R Nelson, Andrew M Tonkin
Progress in Cardiovascular Diseases|July 7, 2026
Caution: very high HDL-cholesterolSultana Monira Hussain, Andrew M Tonkin, John J McNeil
BJOG : an International Journal of Obstetrics and Gynaecology|January 10, 2006
Hormone therapy and cardiovascular disease: a systematic review and meta-analysisDianna J Magliano, Sophie L Rogers, Michael J Abramson, et al.
Pageof 17